Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Gillis Jonathan. Insider active across 1 company, notably MapLight Therapeutics, Inc.. Aggregated, 18 filings have been published. Breakdown: 0 buy · 13 sells. Total volume traded: €3.1m. History available since 27 October 2025. The latest transaction was filed on 17 August 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Gillis Jonathan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations18 total
6,020 shares0Voting Common StockSEC:0001709954-26-000012:0
2,222 shares0Voting Common StockSEC:0001709954-26-000012:1
4,699 shares@ US$36.940.010% mcap4.5% of flowVoting Common StockSEC:0001709954-26-000010:1
900 shares@ US$38.170.0020% mcap0.9% of flowVoting Common StockSEC:0001709954-26-000010:6
5,356 shares@ US$36.130.011% mcap5.0% of flowVoting Common StockSEC:0001709954-26-000010:0
6,979 shares@ US$36.660.015% mcap6.6% of flowVoting Common StockSEC:0001709954-26-000010:2
1,476 shares@ US$37.440.0032% mcap1.4% of flowVoting Common StockSEC:0001709954-26-000010:3
600 shares@ US$36.510.0013% mcap0.6% of flowVoting Common StockSEC:0001709954-26-000010:4
16,969 shares@ US$37.610.037% mcap16.4% of flowVoting Common StockSEC:0001709954-26-000010:5
7,914 shares@ US$28.940.014% mcap11.0% of flowVoting Common StockSEC:0001709954-26-000008:0
29,623 shares@ US$29.600.054% mcap42.0% of flowVoting Common StockSEC:0001709954-26-000008:1
14,363 shares@ US$30.460.027% mcap21.0% of flowVoting Common StockSEC:0001709954-26-000008:2
17,235 shares@ US$30.330.032% mcap25.0% of flowVoting Common StockSEC:0001709954-26-000008:3
700 shares@ US$30.830.0013% mcap1.0% of flowVoting Common StockSEC:0001709954-26-000008:4
3,590 shares@ US$26.610.0058% mcap4.3% of flowVoting Common StockSEC:0001709954-26-000006:0
6,020 shares0Voting Common StockSEC:0001709954-26-000004:0
22,050 shares@ US$17.9815.2% of flowVoting Common StockSEC:0001709954-26-000002:0
30,565 shares0Voting Common StockSEC:0001709954-25-000007:0
About Gillis Jonathan
GILLIS JONATHAN is CAO and Interim CFO at MapLight Therapeutics, Inc. He has reported 16 filings in total, and across the recent filings available they span from 2025-10-28 to 2026-07-20, with EUR 3,060,787 of sales and EUR 0 of purchases; the modal transaction nature is Sale.